Page last updated: 2024-08-21

chenodeoxycholic acid and Cancer of Prostate

chenodeoxycholic acid has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, LA; Bikle, DD; Bogart, JW; Cook, JM; Preston, JV; Sanchez, LM; Silvaggi, NR; Teske, KA; Yu, OB1
Choi, YH; Im, EO; Jin, Y; Kim, ND; Suh, H; Yoo, YH1

Other Studies

2 other study(ies) available for chenodeoxycholic acid and Cancer of Prostate

ArticleYear
Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites.
    European journal of medicinal chemistry, 2016, Feb-15, Volume: 109

    Topics: Calcitriol; Cell Line, Tumor; Cholesterol; Glucuronates; Humans; Lithocholic Acid; Male; Prostatic Neoplasms; Receptors, Calcitriol; Transcription, Genetic; Vitamin D; Vitamin D3 24-Hydroxylase

2016
Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells.
    Cancer letters, 2003, Sep-25, Volume: 199, Issue:2

    Topics: Apoptosis; Blotting, Western; Caspases; Cell Cycle; Cell Cycle Proteins; Chenodeoxycholic Acid; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA-Binding Proteins; DNA, Neoplasm; Dose-Response Relationship, Drug; E2F Transcription Factors; E2F1 Transcription Factor; Humans; Indoles; Luciferases; Male; Phosphorylation; Poly(ADP-ribose) Polymerases; Precipitin Tests; Promoter Regions, Genetic; Prostatic Neoplasms; Retinoblastoma Protein; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ursodeoxycholic Acid

2003